Hennion & Walsh Asset Management, Inc.
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1861642
Parsippany, NJ
Position in ARCT
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,326,511
+$167,390 QoQ
Shares Held
346,207
+23.8% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#16
of 133 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. ARCT ranks #33 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
48,019 | $11,571,138 | |
| 2 | CELC |
Celcuity Inc.
|
100,368 | $10,500,500 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
276,696 | $10,182,412 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
171,470 | $9,741,210 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
342,883 | $7,495,422 | |
| 6 | QURE |
uniQure N.V.
|
142,113 | $6,545,724 | |
| 7 | KURA |
Kura Oncology, Inc.
|
568,845 | $6,240,229 | |
| 8 | ARDX |
Ardelyx, Inc.
|
1,211,690 | $6,179,619 |
All Filings in ARCT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,326,511 | 346,207 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,159,121 | 279,679 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,473,057 | 240,303 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,444,782 | 78,393 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,038,653 | 79,835 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,051,099 | 99,254 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,392,507 | 82,057 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $794,547 | 34,233 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $843,971 | 34,660 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,078,276 | 31,930 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $982,222 | 31,152 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,394,978 | 54,598 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,318,448 | 45,971 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,570,418 | 65,516 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,143,697 | 67,435 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $894,579 | 60,363 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $972,118 | 61,761 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,601,019 | 59,385 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,782,771 | 48,170 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,434,021 | 30,013 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $667,900 | 19,737 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||